Bortezomib Guide
- Summary
- Why it is Prescribed
- Brand Names
- How it Works
- Other Information
- Other Uses
- Overdose
- Precautions
- Possible Side Effects
- Special Dietary Concerns
- Storage Conditions
Why it is Prescribed
Bortezomib is used to treat people with multiple myeloma (a type of cancer of the bone marrow) who have already been treated with at least one other medication. Bortezomib is also used to treat people with mantle cell lymphoma (a fast-growing cancer that begins in the cells of the immune system) who have already been treated with at least one other medication. Bortezomib is in a class of medications called antineoplastic agents. It works by killing cancer cells.
How it Works
Bortezomib comes as a solution (liquid) to inject into a vein. Bortezomib is given by a doctor or nurse in a medical office or clinic. It is usually given on a rotating schedule that alternates 2 weeks when bortezomib is given twice a week with 10 days ...
Keep reading...
Encyclopedia: Bortezomib
Bortezomib is the first therapeutic proteasome inhibitor to be tested in humans. It is approved in the U.S. for treating relapsed multiple myeloma and mantle cell lymphoma. In multiple myeloma, complete clinical responses have been obtained in patients with otherwise refractory or rapidly advancing disease. Bortezomib was originally synthesized in 1995 at a company called Myogenics, which soon changed name to ProScript. After promising preclinical results, the drug was used...
Visual Exploration: Hodgkin's Disease
Layers: (click to view/hide)
Search:
Forum Search
-
Reminder from this week - BLOOD online - "Bortezomib(Velcade)-induced per......
Article Submitted April 1, 2008 Accepted June 2, 2008 Bortezomib-induced peripheral neuropathy * Corresponding author; email: kalofon@med.upatras.gr . Bortezomib, a novel proteosome inhibitor
Jun 24, 2008
-
Brian Durie's NEJM 28Aug2008 Response to San Miguel's NEJM Article...
of combining bortezomib with melphalan plus prednisone, as compared with melphalan plus prednisone with bortezomib is superior to melphalan plus prednisone alone. But how does this clear-cut evidence
Aug 28, 2008
-
FDA Approves VELCADE
FDA Approves VELCADE(R) (Bortezomib) for Injection for Patients with Previously Untreated Multiple with bortezomib compared to 4% for the control arm. Importantly, patients treated with bortezomib also
Jun 20, 2008
Radiation Therapy Slide Show
Radiation therapy treatment planning
This slide show from the Mayo Clinic will guide you through the process of planning for radiation therapy. Before you begin external beam radiation treatment, your radiation therapy team carefully plans every aspect of your treatment in a process called radiation simulation. Radiation therapy treatment planning usually involves positioning your body, making marks on your skin and taking imaging scans.
Documents
-
-
targeted therapies in cancer
Free Medical eBooks to download are available from my blog (asgarcymed.blogspot.com)
Related in the Kosmos
Chemotherapeutic Agents
Pharmacology
Types of Cancer (8)
Protein
Treatment Success for Thalidomide
Thalidomide is a popular treatment for Bortezomib.
| Condition | Members | Success |
|---|---|---|
| Multiple Myeloma | 23 | 91% |
| Neurofibromatosis... | 2 | 100% |
| Amyotrophic Later... | 1 | 100% |
| Depression - Teen... | 1 | 100% |
| Amyloidosis | 1 | 100% |
Overall, 98% (28 members) find Thalidomide helpful.